Efficacy and Safety of AngongNiuhuang Pill for the Treatment of Patients With Acute Ischemic Stroke.
Status:
Unknown status
Trial end date:
2019-12-30
Target enrollment:
Participant gender:
Summary
AngongNiuhuang pill has obvious effects on the cardiovascular and cerebrovascular, especially
the cerebral vessels. Pharmacological experiments confirmed that AngongNiuhuang pill can
protect blood-brain barrier, reduce capillary permeability, improve the tolerance of cerebral
ischemia and hypoxia, improve oxidative stress injury, thus protecting brain tissue. Clinical
studies have also confirmed that AngongNiuhuang pill can increase the GCS score, reduce coma,
improve nerve function defect and promote nerve function recovery. The primary purpose of
this trial was to evaluate the effect of AngongNiuhuang pill and placebo on the improvement
of life function in patients with ischemic stroke at 90 days in acute phase.
Phase:
Phase 3
Details
Lead Sponsor:
Peking Union Medical College Hospital
Collaborators:
Affiliated Hospital of Chengde Medical University Cangzhou Central Hospital China-Japan Friendship Hospital The Second Hospital of Hebei Medical University